Aridis Pharmaceuticals, Inc. (ARDS)
OTCMKTS: ARDS · Delayed Price · USD
0.0570
-0.0030 (-5.00%)
Jul 2, 2024, 3:30 PM EDT - Market closed
Aridis Pharmaceuticals Market Cap
Aridis Pharmaceuticals has a market cap or net worth of $2.54 million as of July 2, 2024. Its market cap has decreased by -88.61% in one year.
Market Cap
2.54M
Enterprise Value
3.94M
1-Year Change
-88.61%
Ranking
n/a
Category
Stock Price
$0.06
Market Cap Chart
Since August 14, 2018, Aridis Pharmaceuticals's market cap has decreased from $102.60M to $2.54M, a decrease of -97.52%. That is a compound annual growth rate of -52.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 18, 2023 | 11.20M | -54.29% |
| Dec 30, 2022 | 24.50M | -25.08% |
| Dec 31, 2021 | 32.70M | -46.48% |
| Dec 31, 2020 | 61.10M | 53.90% |
| Dec 31, 2019 | 39.70M | -55.84% |
| Dec 31, 2018 | 89.90M | -12.38% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 869.02B |
| Novo Nordisk | 643.34B |
| UnitedHealth Group | 455.27B |
| Johnson & Johnson | 352.43B |
| Merck & Co. | 323.95B |
| AbbVie | 300.85B |
| AstraZeneca | 241.65B |
| Novartis AG | 208.44B |